KEQU logo

KEQU
Kewaunee Scientific Corporation

164
Mkt Cap
$126.69M
Volume
3,890.00
52W High
$71.33
52W Low
$30.33
PE Ratio
10.69
KEQU Fundamentals
Price
$44.21
Prev Close
$45.36
Open
$44.00
50D MA
$47.86
Beta
0.64
Avg. Volume
15,359.48
EPS (Annual)
$3.83
P/B
1.89
Rev/Employee
$194,085.55
Loading...
Loading...
News
all
press releases
The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific
NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight strong niche and microcap opportunities.
Zacks·11d ago
News Placeholder
More News
News Placeholder
Top Stock Reports for NVIDIA, Roche & Lam Research
NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.
Zacks·11d ago
News Placeholder
Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%
KEQU's Q1 revenues and EPS grow y/y, aided by Nu Aire, yet shares drop 19% as investors weigh uneven project timelines and rising costs.
Zacks·2mo ago
News Placeholder
The Zacks Analyst Blog Highlights Lowe's, Bristol-Myers Squibb, Marvell Technology and Kewaunee Scientific
Zacks spotlights Lowe's, Bristol Myers, Marvell, and Kewaunee Scientific as earnings, strategy, and acquisitions shape growth outlooks.
Zacks·2mo ago
News Placeholder
Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology
Lowe's leans on Pro-focused strategy and AI-powered retail tools, Bristol-Myers banks on new drug launches to offset legacy declines, and Marvell rides AI-driven data center growth despite consumer softness.
Zacks·2mo ago
News Placeholder
Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog
KEQU earns an upgrade to "Outperform" as Nu Aire integration drives sales growth, margins expand and a record backlog boosts visibility, offsetting tariff risks with proactive inventory strategies.
Zacks·2mo ago
News Placeholder
The Zacks Analyst Blog Highlights NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific and Natural Health Trends
NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific, and Natural Health Trends show strong market momentum, each leveraging unique growth drivers despite sector-specific challenges.
Zacks·3mo ago
News Placeholder
Top Research Reports for NVIDIA, Palantir & Coca-Cola
PLTR's soaring stock, AI momentum, and S&P 500 inclusion make it a standout in today's top research reports.
Zacks·3mo ago
News Placeholder
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
KEQU posts strong Q4 and FY25 results, driving a 47% stock surge as sales jump and the Nu Aire acquisition boosts growth momentum.
Zacks·4mo ago
News Placeholder
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 PR Newswire STATESVILLE, N.C., Dec. 11, 2024...
PR Newswire·11mo ago

Latest KEQU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.